HYPE: Your smartwatch can detect sleep apnoea, so you no longer need a sleep test.
But what does the evidence actually show?
Selected, validated smartwatch features can flag possible moderate-to-severe obstructive sleep apnoea. They do not diagnose it, identify every case or make a normal watch result an all-clear.
Claim assessed: Screening for possible obstructive sleep apnoea with validated wrist-worn consumer software, rather than diagnosing it or monitoring established treatment.
Why it sounds plausible
A pause or reduction in breathing can change movement, oxygen levels and pulse patterns. Sensors on a wrist can detect some of those signals, and an algorithm can look for patterns associated with obstructive sleep apnoea. That gives the idea a credible basis. The important test is comparison with an appropriate clinical reference, not whether a watch produces an impressive sleep score. [1][2]
What Apple's validation actually found
Apple's published clinical validation reported 66.3% sensitivity and 98.5% specificity for its notification feature against the study's moderate-to-severe threshold. Those figures describe a particular algorithm, protocol and reference test. They are manufacturer-reported evidence, not an independent verdict on every smartwatch. [1]
Sensitivity describes how often people meeting the disease threshold are flagged. Roughly two thirds were identified in that validation, leaving a substantial minority without a notification. Specificity describes how often those below the threshold avoid an alert. It does not mean an alerted person has a 98.5% chance of having the condition; that probability also depends on how common it is in the population being screened. [1]
Other validated watches are a separate question
The FDA's review of Samsung's sleep-apnoea feature reported sensitivity of 82.7% in its study. Its hardware, oxygen-based approach, eligibility and study protocol differ from Apple's movement-based feature. Comparing headline percentages cannot establish which is best for an individual or prove that every similarly named app works. [2]
Regulatory authorisation is specific to the stated feature and intended use. It is not permission to reinterpret an ordinary sleep-stage estimate as a diagnostic test. Availability and supported hardware also vary by country and software version. Check the actual instructions for the feature you own. [1][2]
The catch: screening is not diagnosis
These systems focus on possible moderate-to-severe obstructive sleep apnoea. Mild disease, other sleep disorders and some affected users may be missed. Sensor contact, usable recording nights and eligibility restrictions matter. A reassuring score cannot explain persistent sleepiness or witnessed breathing pauses. [1][2]
NICE recommends a clinical pathway beginning with home respiratory polygraphy for suspected obstructive sleep apnoea, with further testing when indicated. A sleep laboratory is not necessary for every initial assessment, but an appropriate clinical test is still different from an unsolicited wrist alert. [3]
What this means for you
Treat a notification as a reason to discuss assessment with a clinician. If someone notices breathing pauses or you have persistent excessive daytime sleepiness, seek advice even if the watch has never alerted you. Do not change prescribed sleep-apnoea treatment because a watch score improves. [3]
Before relying on a feature, ask what condition it screens for, who it was validated in and what its instructions say a negative result means. A useful early warning can help someone access care without replacing that care.
A validated watch can raise a useful flag. It cannot give every sleeper a reliable all-clear.
Research & Sources
Check the evidence yourself. Access limitations and indirect evidence are identified below.
1. Apple (2024). Estimating Breathing Disturbances and Sleep Apnea Risk from Apple Watch.
Manufacturer clinical validation and intended-use limitations; not independent comparative evidence.
Read the original source ↗2. FDA (2024). De Novo review: Samsung Sleep Apnea Feature, DEN230041.
Regulatory clinical-performance review for the specified feature.
Read the original source ↗3. NICE NG202. Obstructive sleep apnoea/hypopnoea syndrome: recommendations.
Clinical diagnostic pathway, checked October 2026.
Read the original source ↗Evidence reviewed: October 2026
Targeted editorial review of sources available on 24 October 2026, not an exhaustive systematic review. Evidence vs Hype provides education, not individual medical diagnosis or treatment. Original AI-generated artwork is illustrative and does not show a study result. No commercial product was selected or endorsed.
